StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CYTK

Cytokinetics, Incorporated

CYTK Nasdaq Pharmaceutical Preparations EDGAR ↗
$76.45
-3.97 -4.94%

Key statistics

from XBRL data in SEC filings
Market cap
$9.51B
Revenue (TTM)
$106M
Net income (TTM)
-$830M
EPS (TTM)
$-6.85
P/E ratio
Dividend yield
Free cash flow
-$535M
Cash
$130M
Total assets
$1.27B
Gross margin
52-week range
$32.89 – $88.31

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results May 27, 2026 8-K Other events May 8, 2026 8-K Other events May 5, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Other events Feb 17, 2026 8-K Other events Dec 19, 2025 8-K Other events Dec 12, 2025 8-K Director or officer change Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Sep 22, 2025 8-K Other events Sep 16, 2025 8-K/A Other events Sep 8, 2025 8-K Other events Sep 3, 2025 8-K Other events Sep 2, 2025 8-K Director or officer change Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results May 16, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Other events May 1, 2025 8-K Regulation FD disclosure Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Director or officer change Feb 11, 2025 8-K Director or officer change Dec 16, 2024 8-K Entered a material agreement Nov 19, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Director or officer change Nov 7, 2024 8-K Director or officer change Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events Jun 7, 2024 8-K Regulation FD disclosure Jun 5, 2024 8-K Other events May 28, 2024 8-K Other events May 22, 2024